SAB Biotherapeutics (SABS) Capital Expenditures (2021 - 2026)
SAB Biotherapeutics (SABS) reported Capital Expenditures of $1.59 million for Q2 2026, up 61.3% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' Capital Expenditures came in at $2.72 million; for FY2025, it was $933,156, up 176.7% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -40.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $337,262 in FY2024 (+71.1%), $197,154 in FY2023 (-90.9%), $2.17 million in FY2022 (-80.2%) and $10.94 million in FY2021 (-14.0%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q4 2021.
- The high point for year-over-year Capital Expenditures in five years was Q1 2024 (growth of 506.0%); the low point was Q1 2023 (a decline of 98.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.76 Bn | 1,104.34 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.07 Bn | 537.60 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.11 Bn | 476.22 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.23 Bn | 324.61 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.76 Bn | 262.75 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.14 Bn | 234.83 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.54 Bn | 192.94 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.65 Bn | 165.84 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.26 Bn | 116.90 Bn | 10.94 Bn | 533.00 Mn |
| 10 | SAB Biotherapeutics | 224.90 Mn | -192.59 Mn | - | 1.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 983,257.00 |
| Dec 31, 2024 | 55,377.00 |
| Sep 30, 2024 | 100,300.00 |
| Jun 30, 2024 | 52,511.00 |
| Mar 31, 2024 | 129,074.00 |
| Dec 31, 2023 | 67,864.00 |
| Sep 30, 2023 | 85,306.00 |
| Jun 30, 2023 | 22,684.00 |
| Mar 31, 2023 | 21,300.00 |
| Dec 31, 2022 | 117,754.00 |
| Sep 30, 2022 | 78,504.00 |
| Jun 30, 2022 | 612,832.00 |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 1.89 Mn |
API Access
SAB Biotherapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();